Article Details
Retrieved on: 2021-04-27 13:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AUSTIN, Texas — Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in ...
Article found on: news.utexas.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here